Aesthetic Medicine
Aesthetic Medicine


14 MIN READ TIME

News and analysis

Dermal filler market set for increased growth over next five years

The dermal fillers market is expected to grow at a CAGR (compound annual growth rate) of 8.6% by 2026, according to a report by Transparency Market Research.

The market was valued at $2,584.9 million (£1824.3m) in 2017 but is now expected to grow to $5,411.2m (£3,819m) thanks to the development of new hyaluronic acid dermal fillers, enhanced marketing strategies from brands and increasing awareness of the role of fillers in anti-ageing on social media.

HA fillers are predicted to hold dominance in the market across the forecast period, with 60% of procedures globally performed with this type of filler, growing as new products come to market with differing concentrations of HA and degrees of crosslinking, offering enhanced longevity and effects and a wider choice for practitioners.

In terms of application, facial line correction, which can also be thought of as volume restoration, is expected to remain the most popular treatment across the forecast period, compared to lip enhancement, scar treatment and others. The report attributes this to the varied age demographic of those seeking general rejuvenation, from young adults wanting to beautify to middle-aged and older adults who desire anti-ageing maintenance. 

The dermatology clinics segment is expected to expand at a robust rate in terms of end user as more people become educated to the specialism of aesthetic medicine and seek dermatology specialists for treatment.

While the US was the major revenuegenerating country in the market in 2017, the market in Asia Pacific is forecasted to grow between now and 2026, attributed to increasing demand for dermal filler treatments in Japan, India and China.

Leading market players include Allergan, Sinclair Pharma, Merz Pharma, Galderma and Teoxane.


“Skinxiety” phenomenon coined by BCAM president Dr Uliana Gout

Dr Uliana Gout, British College of Aesthetic Medicine (BCAM) president and Aesthetic Medicine editorial board member, has suggested that “skinxiety” is a new worldwide phenomenon.

Dr Gout coined the term, which refers to people’s anxiety about their appearance caused by pandemic-related issues such as “maskne” and “Zoom face”, to highlight the problems that she and other global aesthetic clinicians are seeing in their clinics as restrictions are lifted.

Dr Gout said: “The past year has been tough for everyone for many reasons and in clinics we’ve seen a real surge of patients who have serious concerns about their skin. Worries about open pores, congestion, spots, blemishes, and pigmentation are significantly affecting their wellbeing and in turn they are seeking professional help. This is a welcoming sign for our specialty as we have long been advocating the public to seek medical advice when it comes to looking after the biggest organ in our body – the skin.

“Skinxiety is a new phenomenon, it’s not something we’ve seen to this extent before and there’s a direct correlation between patients’ concerns about their skin and the pandemic,” she added.

Dr Gout took over as president of BCAM just before the pandemic hit. Since then, much of the college’s work has been focused on supporting its 400 members through a challenging time by working closely with the Department of Health and Social Care and key stakeholders within the UK industry. In addition, BCAM launched its 20th Anniversary Mindfulness and Wellbeing Initiative to support members with their holistic wellbeing and mental health.



New fast–track route to JCCP register available for practitioners via Learna online learning platform

Aesthetic practitioners who want to be accepted onto the JCCP (Joint Council for Cosmetic Practitioners) register can now do so via an officially recognised fast track course.

The JCCP Fast Track Assessment from online learning platform Learna has been developed alongside the JCCP to enable more practitioners to be able to join Part One of its Practitioner Register, which requires practitioners to undertake a formal qualification to demonstrate their knowledge, skill and competence in cosmetic medicine to achieve full and unconditional registration.

The Fast Track Assessment gives a more affordable and quicker route to the register, as opposed to Cosmetic Medicine PgCert, PgDip and other related postgraduate or Level 7 vocational programmes.

The Assesment results in the award of a formally recognised equivalent verification standard that equates to the JCCP Level 7 education and training standard for the injection of toxins and for the insertion of dermal fillers. Practitioners undergo two components; a three-hour theoretical exam testing practitioner knowledge, and an Objective Structured Clinical Exam (OSCE) which tests clinical skills and competence.

Learna is the only approved educational provider in the UK to deliver the exam part of the assessment.

Professor David Sines CBE, chair of the Joint Council for Cosmetic Practitioners, said: “The concept of the Fast Track Assessment Centre was envisaged in 2018 and has always been central to the JCCP’s strategy to provide accomplished and experienced healthcare-regulated practitioners with a more accessible entry route to enable them to achieve entry to the Council’s Practitioner Register…This new development heralds a new era for the enhancement of public safety in the UK.”

The first assessment dates for the Fast Track Assessment will take place at the end of June.


Health and beauty ad complaints up 40% in 2020, including medical aesthetics sector, says ASA report

The health and beauty industry was responsible for more adverts that were amended or withdrawn than any other industry in 2020, according to the Advertising Standards Authority (ASA) and Committees of Advertising Practice (CAP) Annual Report 2020, which highlights particular issues for advertising regulation around beauty and medical aesthetics.

Complaints against health and beauty ads were up 40% year-on-year, with 5,285 complaints registered in 2020 in comparison to 3,779 in 2019, the data found. The sector also reported 3,088 cases with the regulators during 2020, which equated to 16%.

Some of the key issues surrounding ads focused on body image, specifically limiting young people’s exposure to ads for cosmetic procedures and posts that promote dangerous weight loss.

In January 2020, the ASA stated that it was cracking down on clinics and beauty salons illegally advertising anti-wrinkle injections on social media. For example, the ASA banned an ad from Royal Tunbridge Wells Skin Clinic Ltd in 2019 for “normalising lip fillers for young women and teenagers and presenting this as something responsible parents should support”, the report states. Meanwhile, it also banned a post by TV personality Gemma Collins for Skinny Jabs Ltd as it promoted a prescriptiononly medicine on social media.

“2020 heightened concerns about putting on weight as a consequence of the covid-19 pandemic. This context made it even more important that we investigated and published rulings against three advertisers promoting the use of licensed injectable prescription-only medicine for weight loss, including by influencers on Instagram,” the report says.

Although complaints about influencer posts (across all industries) decreased by 8% in 2020, they still made up almost a quarter of online cases, the report found. Cracking down on poor advert labelling on social media has been a key task, with CAP monitoring Instagram Stories of 122 influencers in September 2020 over 21 consecutive days to assess whether the content was being properly labelled. When it came to comparing ad disclosure on social media across sectors, of the 1,406 beauty-related posts monitored, there was a 45% compliance rate, the report states.

The ASA is the UK’s independent regulator of advertising across all media, while CAP writes the UK advertising codes and provides authoritative guidance on the rules.


NEWS IN BRIEF

Award win for AlumierMD

Clinical skincare brand AlumierMD was awarded Most Innovative Medical- Grade Skincare Brand UK by the Global Health and Pharma Awards 2021. It was recognised as one of the fastestgrowing medical skincare brands in the UK and was also celebrated for its commitment to development, quality of projects and design solutions and social medica presence. The awards panel commented, “AlumierMD provide only the most innovative and cuttingedge medical grade products, providing customers with a guarantee of safe and socially responsible ingredients.”

BCAM Conference open for registrations

The British College of Aesthetic Medicine (BCAM) has opened registrations for its Virtual Annual Conference on 10-11 September. The agenda is to include skincare, fat reduction and muscle toning, skin tightening and talks relating to covid-19. The cost is £99.50 for BCAM members and £125 for non-members. Register: bcamconference.co.uk

Croma Pharma launches e-learning platform

Croma Pharma has developed an interactive e-learning platform to offer healthcare practitioners continuing education in minimally invasive aesthetics. Series include Social Media and Online Marketing, Facial Anatomy Workshops, Aesthetic Start-up Academy and Aesthetic Excellence. Each contains a variety of topics and grants HCPs lifetime access to learn at their own pace. More information: learn.cromaismore.com

Dr Osman Bashir Tahir opens first clinic outside Pakistan

UK-trained plastic surgeon Dr Osman Bashir Tahir has launched his first international location in London, adding to two clinics in Lahore, Pakistan. Halcyon Clinic offers an extensive range of non-surgical procedures including dermal fillers, Aqualyx, Profhilo; and signature treatments Angel Lips and liquid neck rhinoplasty. “I have launched Halcyon Clinic in London to expand my network of trusted clinics... London is internationally acclaimed as a city with aesthetic excellence that recognises global consumer needs with a holistic approach,” said Dr Bashir Tahir.

5:2 intermittent fasting diet found to reduce psoriasis symptoms

New research has found a link between intermittent fasting and a reduction in psoriasis symptoms. In the first study to investigate the effects of modified intermittent fasting (MIF) in the format of a 5:2 diet – eating normally for five days and restricting calorie intake on two nonconsecutive days – preliminary findings showed a significant reduction in scaling and thickness of the skin in patients with mild psoriasis after following the diet.

The study sought to provide evidence to inform whether there is a link between gut health and psoriatic lesions, as well as uncover any benefits of MIF in psoriasis management.

24 subjects with mild psoriasis were enrolled in the 12-week study, with half instructed to modify their diet with MIF, while the other half continued their regular diet. Replicating the 5:2 diet, the fasting group was asked to consume a total of 500 calories on two non-consecutive days of the week but were free to consume their usual calories for the remaining days.

Fasting subjects reported significant improvement more frequently at weeks six and 12, mentioning less scaling and thickening, with 30% also reporting a decrease in itching. Waist circumference and weight were comparable between the groups at six weeks but reduced significantly in the fasting group at week 12 compared to the control group.

“...The results of this study add to the growing body of evidence being undertaken to understand the relationship between the gut and skin, with some promising results for patients and the disease management of psoriasis, said Professor Marie-Aleth Richard, European Academy of Dermatology and Venerology board member and professor at the University Hospital of La Timone, Marseille.

The research was presented at the EADV Spring Symposium in May.


Sinclair Pharma takes on Cocoon Medical

Aesthetics Company Sinclair Pharma (Ellansé, Silhouette, Perfectha, Lanluma) is entering the energy-based devices market with the acquisition of Cocoon Medical.

Spanish-founded Cocoon Medical has an extensive portfolio of non-invasive lasers and cryoadipolisis devices such as the Cooltech Define, Primelase and Elysion for clinics and medi-spas.

The manufacturer has a direct presence in Europe, Latin America, Hong Kong and the US and manages a network of over 60 distributors in other countries.

“...Cocoon’s products combine outstanding technology, build quality and user flexibility with competitive pricing to generate an industry-leading value proposition. The company has a rich product development pipeline to sustain its technological edge for several years,” said Chris Spooner, chief executive of Sinclair.


Hand hygiene during pandemic blamed for high rates of dermatitis

New research presented at the EADV 2021 Spring Symposium has highlighted the effects of the pandemic on hand skin health, finding hand dermatitis present among 93% of healthcare professionals (HCPs) and 69% of the general population surveyed, despite only 3% of HCPs and 2% of the general public in the study reporting a prior history. Both the HCPs and participants from the general public stated that skin irritation and dryness was the main barrier to the consistent practice of hand hygiene.

Dr Monisha Madhumita, from Father Muller Medical College in Mangalore, India, said: “This research truly demonstrates the impact of increased hand washing and uptake of alcoholbased rubs on hand skin health. Finding suitable modifications to practices and products that may increase the accessibility of proper hand hygiene is of vital importance.”



Google to launch AI–powered dermatology diagnosis smartphone tool for Android users

Google is planning to pilot-launch a tool that turns a user’s smartphone camera into a health tool to identify dermatological issues.

Announced at this year’s Google I/O conference in May, the dermatology-assist tool for Android smartphones is powered by artificial intelligence. It asks the user to take three pictures of their concern – either skin, nails or hair – then answer questions relating to symptoms.

The tool then searches a database of 288 skin conditions to give a list of potential causes. The user is shown dermatologist information and answers to frequently asked questions before being prompted to conduct their own further research.

While the tool has received clinical validation in the EU, it is yet to be approved by the FDA for safety or efficacy.


UK is second most–interested in teeth–whitening services globally

The UK ranks second behind only the US in terms of interest and demand for teeth-whitening services. A survey by ExpressDentist.com used an online analytics tool to find out which countries had the highest annual search volumes for the search term “teeth whitening”.

The UK came in second, with 576,000 searches a year, trumped only by the US, where people collectively searched for teeth whitening 960,000 times. All together there were 4,541,400 searches from the top 50 countries, with Iceland ranking last, with only 1,800 searches annually.

Turkey was ranked third “most concerned”, with 396,000 online searches per year. This is likely to do with the country’s huge involvement in the aesthetic treatment and cosmetic surgery markets, with Brits now regularly travelling there for cheaper dental work.

ExpressDentist.com looked at the average monthly searches per country and multiplied this figure to get the annual search number.


Hair loss biomarker can determine covid-19 disease severity in men, say researchers

Researchers have discovered a novel biomarker to identify male covid-19 patients most at risk for ICU admission. The findings suggest that men with genetic characteristics (phenotypes) sensitive to the male sex hormone androgen, are more likely to experience severe covid-19 disease.

Researchers were driven to study the association between the androgen receptor (AR) gene and covid-19, after observing the disproportionate number of men hospitalised with covid-19 presenting with androgenetic alopecia compared to the expected number in a similar agematched population (79% vs. 31-53%).

Dr Andy Goren, chief medical officer at Applied Biology in California, US, explained: “The identification of a biomarker connected with the androgen receptor is another piece of evidence highlighting the important role of androgens in covid-19 disease severity.”

NEWS IN BRIEF

Blow Media launches AI bot to increase clinic enquiries

Blow Media has announced the launch of BlowBot. The bot has been specifically designed to drive online enquiries for clinics using AI technology to answer queries and book appointments from visitors to clinic websites. Combined with a complete enquiry management system, the company claims that BlowBot has been proven to increase enquiries by an average of 240%.

BTC announces Supercharged Weekender training

Dr Harry Singh has created a new BTC (Botulinum Toxin Cub) course – the Supercharged Weekender. Designed to help delegates boost their business, skillset and confidence, the intimate course is only open to nine delegates. The course will be led by three trainers with three botulinum toxin and three lip models per delegate. It will also cover complications and feature a marketing masterclass. The course takes place on 26-27 June in Stevenage and includes overnight accomodation and drinks and dinner on the first night. To book your place: 0800 047 2038.

GetHarley creates Sales Masterclass with Dr Nina Bal

Professional skincare-retailing platform GetHarley has teamed up with Dr Nina Bal to help practitioners make a success of working with the service. Dr Bal, who was an early adopter of the technology, now earns an average of £10,000 profit per month. She will virtually guide attendees through her own journey and share top tips on how to sell skincare even when busy and how to best convert consultations into product sales in a 30-minute webinar on 10 June. Contact: practitioners@getharley.com

Book lifts the lid on male grooming market

Aesthetic practitioner Dr David Jack and lifestyle columnist and magazine editor Jeremy Langmead have teamed up to author a book for men interested in looking good. Pitched as “A shameless guide for men who want to look their best”, Vain Glorious is also available in e-book format. Dr Jack provides medical expertise, while Langmead test-drives the procedures and products on offer, sharing snapshots of his own journey of aesthetic rejuvenation.

This article appears in the June 2021 Issue of Aesthetic Medicine

Click here to view the article in the magazine.
To view other articles in this issue Click here.
If you would like to view other issues of Aesthetic Medicine, you can see the full archive here.

COPIED
This article appears in the June 2021 Issue of Aesthetic Medicine